Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heron Neutron Medical is a Taiwan-based medtech company specializing in the development and manufacture of AB-BNCT systems—a next-generation cancer radiotherapy platform. Their technology enables more precise and effective cancer treatment by using accelerator-generated neutrons to target tumors loaded with boron-containing agents. The company provides complete BNCT solutions including cyclotron accelerators, neutron source systems, beam shaping assemblies, treatment planning/control software, and radiation shielding services. Clinical results are not detailed publicly but the company positions itself as a leader in this emerging field with installations in Taiwan and expansion into Asia-Pacific and Western markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heron Neutron Medical.